Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohortY Q Li, Geoffrey Liu, Khaleeq Khan et al.|Lung Cancer|2024Cited by 4
Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrenceNiki Esfahanian, Geoffrey Liu, Sze Wah Samuel Chan et al.|Cancer Treatment and Research Communications|2023Cited by 2
Identification of immunotherapy early treatment failure in non-small cell lung cancer (NSCLC) using a novel cell-free DNA (cfDNA) tissue-agnostic genome-wide methylome enrichment assay.Tuan Hoang, Adrian G. Sacher, Yahan Yang et al.|Journal of Clinical Oncology|2025Cited by 1